CAPTRUST Financial Advisors
XPH icon

CAPTRUST Financial Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,327
Closed -$216K – 2733
2025
Q2 		$216K Hold
5,327
– – ﹤0.01% 2252
2025
Q1 		$233K Sell
5,327
-500
-9% -$22.1K ﹤0.01% 2093
2024
Q4 		$251K Buy
5,827
+500
+9% +$22.7K ﹤0.01% 2012
2024
Q3 		$236K Sell
5,327
-10
-0.2% -$428 ﹤0.01% 2036
2024
Q2 		$212K Buy
5,337
+63
+1% +$2.55K ﹤0.01% 2007
2024
Q1 		$227K Hold
5,274
– – ﹤0.01% 1934
2023
Q4 		$220K Sell
5,274
-2
-0% -$76 ﹤0.01% 2333
2023
Q3 		$210K Buy
5,276
+300
+6% +$12.7K ﹤0.01% 2255
2023
Q2 		$204K Buy
+4,976
New +$205K ﹤0.01% 2253
2022
Q3 		– Sell
-1,463
Closed -$61K – 4104
2022
Q2 		$61K Buy
1,463
+75
+5% +$3.15K ﹤0.01% 2593
2022
Q1 		$63K Buy
1,388
+261
+23% +$11.5K ﹤0.01% 2622
2021
Q4 		$52K Buy
1,127
+1,053
+1,423% +$49.9K ﹤0.01% 2640
2021
Q3 		$4K Hold
74
– – ﹤0.01% 4060
2021
Q2 		$4K Hold
74
– – ﹤0.01% 3968
2021
Q1 		$4K Hold
74
– – ﹤0.01% 3830
2020
Q4 		$4K Buy
+74
New +$3.54K ﹤0.01% 2946
2020
Q3 		– Sell
-74
Closed -$3K – 3264
2020
Q2 		$3K Buy
+74
New +$3.06K ﹤0.01% 2531
2018
Q4 		– Sell
-200
Closed -$10K – 1685
2018
Q3 		$10K Hold
200
– – ﹤0.01% 1237
2018
Q2 		$9K Hold
200
– – ﹤0.01% 1213
2018
Q1 		$8K Sell
200
-140
-41% -$6.1K ﹤0.01% 1093
2017
Q4 		$15K Buy
340
+140
+70% +$5.95K ﹤0.01% 887
2017
Q3 		$8K Buy
+200
New +$8.48K ﹤0.01% 453

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

CAPTRUST Financial Advisors's XPH Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2025, closing a stake of 5,327 shares — an estimated $216K sold.

CAPTRUST Financial Advisors first reported a position in XPH in Q3 2017 and held it in 22 quarters. The position peaked at $251K in Q4 2024. 69 funds tracked by Wall St. Rank hold XPH as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 5,327 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2025, an estimated $216K.
  • CAPTRUST Financial Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2017 and held it in 22 quarters.
  • CAPTRUST Financial Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $251K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.